信号受容領域の外の生殖線IκBα変異はNFκB1の核転移を阻害し,自己炎症のような特徴と関連している
Abdulwahab Elsayed1, Ignatius Ryan Adriawan1, Faranaz Atschekzei1
1Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; Hannover Medical School, Cluster of Excellence RESIST (EXC 2155), Hannover, Germany.
Annals of the rheumatic diseases
|September 6, 2025
まとめ
新しいNFKBIA遺伝子変異は,NFκBシグナル伝達と炎症体の活性化に影響を与える可能性があります. 免疫不全に関連したN末端の変異体とは異なり,C末端の欠損変異体は自己炎症性関節炎と疹を引き起こす.
科学分野:
- 免疫学
- 遺伝学
- 分子生物学
背景:
- カッパBαの阻害剤は,核因子カッパB (NFκB) の正規活性化を調節する.
- IκBαのN端における機能獲得NFKBIA変異は,結合免疫不全を引き起こす.
- 他のIκBαドメインにおけるNFKBIA変異の影響は,ほとんど記述されていない.
研究 の 目的:
- IκBα N端を超えた領域に影響を与えるNFKBIA変異の機能的影響を調査する.
- 自己炎症性疾患の家族で見つかった新しいC端のNFKBIA変種 (p.Gln228*) を特徴付ける.
主な方法:
- NFKBIAの変異を特定するための全エクソムのシーケンシング
- IκBα発現を定量化するためにフローサイトメトリーとウェスタン・ブロッティングを行う.
- IκBαの分解,NFκB1の活性化,核転移,および炎症体の活性性を評価する試験.
主要な成果:
- p. Gln228* NFKBIA変異は誘発されたIκBα分解に影響を与えなかったが,NFκBの活性化を低下させた.
- p. Gln228* 変異の患者からの外周血液単核細胞は,核NFκB1 p50レベルを低下させた.
- 患者は,NFκB1の機能不全を示唆する, IL- 18の上昇,炎症性粒子の形成の強化,およびIL- 1βの分泌を示した.
結論:
- IκBα信号受容領域外のNFKBIA変異は,IκBα機能と正規のNFκB活性化を損なう可能性があります.
- 免疫不全を引き起こすN末端の変異体とは異なり,このC末端のIκBα欠失は,自己炎症性関節炎およびと関連しています.
関連する概念動画
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K


